AAVOT — Our Core Technology - Aavocyte, Inc. AAVOT: T Cell Immunotherapy for Solid TumorsWe use cookies to analyze website traffic and optimize your website experience By accepting our use of cookies, your data will be aggregated with all other user data
About Us - Aavocyte, Inc. AAVOT: T Cell Immunotherapy for Solid TumorsAavocyte, Inc is a biotech company registered in the State of Washington in 2019 Aavocyte specializes in developing various precise targeting T cell immunotherapy products to treat solid tumors
Whats New - Aavocyte, Inc. AAVOT: T Cell Immunotherapy for Solid TumorsFDA responded to our pre-IND package by providing its clear and complete guidance, which was sufficient for us to finalize the IND package
Contact Us - Aavocyte, Inc. A rAAV Based Precisely Targeted Cell Immunotherapy Product (non-gene therapy) Development Platform